Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 7, 2013
Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)Michael S Roberts, David C Turner, Thandranese S Owens, et al.Neuro-Oncology|November 7, 2015
Phase I study of 5-fluorouracil in children and young adults with recurrent ependymomaKaren D Wright, Vinay M Daryani, David C Turner, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 24, 2016
Simvastatin Hydroxy Acid Fails to Attain Sufficient Central Nervous System Tumor Exposure to Achieve a Cytotoxic Effect: Results of a Preclinical Cerebral Microdialysis StudyYogesh T Patel, Megan O Jacus, Abigail D Davis, et al.Blood|September 19, 2013
Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemiaEric I Zimmerman, David C Turner, Jassada Buaboonnam, et al.CPT: Pharmacometrics & Systems Pharmacology|January 16, 2023
Model-based meta-analysis of non-small cell lung cancer with standard of care PD-1 inhibitors and chemotherapy for early development decision makingDavid C Turner, Russ Wada, Helen Zhou, et al.Clinical and Translational Science|May 29, 2024
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphomaBrendan Bender, Chi-Chung Li, Mathilde Marchand, et al.Clinical Pharmacology and Therapeutics|June 27, 2025
Tocilizumab Dosing for Management of T Cell-Engaging Bispecific Antibody-Related CRS in Patients With R/R B-Cell NHLCandice Jamois, David C Turner, Leonid Gibiansky, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2018
Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic ClearanceDavid C Turner, Anna G Kondic, Keaven M Anderson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2014
Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosingDavid C Turner, Fariba Navid, Najat C Daw, et al.Journal of Neuro-Oncology|November 20, 2014
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC studyRoger J Packer, Brian R Rood, David C Turner, et al.Pageof 3